Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
Scalorbi, Federica, Argiroffi, Giovanni, Baccini, Michela, Gherardini, Luca, Fuoco, Valentina, Prinzi, Natalie, Pusceddu, Sara, Garanzini, Enrico Matteo, Centonze, Giovanni, Kirienko, Margarita, Seregni, Ettore, Milione, Massimo, Maccauro, Marco
Published in Scientific reports (30.09.2021)
Published in Scientific reports (30.09.2021)
Get full text
Journal Article
1180P Single-institution real-life experience of 177Lu-DOTATATE treatment in progressive, well differentiated GEPNETs
Scalorbi, F., Lorenzoni, A., Fuoco, V., Argiroffi, G., Prinzi, N., Pusceddu, S., Aliberti, G., Coppa, J., De Braud, F.G.M., Mazzaferro, V., Seregni, E.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1105P Predictive factors of adverse events onset in GEPNET patients treated with PRRT
Scalorbi, F., Argiroffi, G., Lorenzoni, A., Baccini, M., Gherardini, L., Fuoco, V., Prinzi, N., Pusceddu, S., Calareso, G., Garanzini, E., Centonze, G., Milione, M., Chiesa, C., Seregni, E., Maccauro, M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article